Amarin’s Vascepa Omega-3 Drug Aims to Eliminate Dietary Supplement Competition with International Trade Commission Complaint, CRN Says

Sep 7, 2017

Amarin’s ITC complaint alleges that synthetically produced omega-3 products that are predominantly composed of EPA in either ethyl ester or re-esterified form are not considered “dietary ingredients” under Section 201(ff)(1) of the Federal Food Drug and Cosmetic Act, and thus, are not legal dietary supplements but unapproved new drugs.